Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
3 results
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Persistent immune-related adverse events after cessation of checkpoint inhibitor therapy: Prevalence and impact on patients' health-related quality of life.
Eur J Cancer. 2022 Nov;176:88-99. doi: 10.1016/j.ejca.2022.08.029. Epub 2022 Oct 2.
Eur J Cancer. 2022.
PMID: 36198246
Development of Lymphopenia during Therapy with Immune Checkpoint Inhibitors Is Associated with Poor Outcome in Metastatic Cutaneous Melanoma.
Tomsitz D, Schlaak M, Zierold S, Pesch G, Schulz TU, Müller G, Zecha C, French LE, Heinzerling L.
Tomsitz D, et al. Among authors: schulz tu.
Cancers (Basel). 2022 Jul 5;14(13):3282. doi: 10.3390/cancers14133282.
Cancers (Basel). 2022.
PMID: 35805052
Free PMC article.
Item in Clipboard
Health-related quality of life (EuroQol 5D-5L) in patients with autoimmunity in the context of immunotherapy: A large dataset comprising cancer patients after cessation of checkpoint inhibitor therapy and patients with autoimmune diseases.
Schulz TU, Zierold S, Sachse MM, Pesch G, Tomsitz D, Schilbach K, Kähler KC, French LE, Heinzerling L.
Schulz TU, et al.
Data Brief. 2022 Oct 14;45:108676. doi: 10.1016/j.dib.2022.108676. eCollection 2022 Dec.
Data Brief. 2022.
PMID: 36426068
Free PMC article.
Item in Clipboard
Cite
Cite